Cardio Catch-Up: Medtronic, Abbott, Ancora Devices Headline ACC, CRT, THT

 
• By Reed Miller

Medtech Insight’s Cardiovascular Catch-Up highlights recent news on cardiovascular tech innovations that you may have missed. This edition focuses on clinical trial presentations from three recent conferences: American College of Cardiology in New Orleans, Cardiovascular Research Technologies in Washington, DC, and Technology and Heart Failure Therapeutics in Boston.

Triclip transcatheter tricuspid repair device
Abbott's TriClip transcatheter tricuspid repair device • Source: Abbott

One-year results from the TRILUMINATE trial showed that percutaneous tricuspid transcatheter edge-to-edge repair (TEER) with Abbott’s TriClip device can improve the quality of life for patients with severe tricuspid valve regurgitation.

Paul Sorajja from the Minneapolis Heart Institute presented the results at the American College of Cardiology conference on 4 March. The results are also published in The New England...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Business

More from Medtech Insight